Dual atrioventricular-nodal physiology, elicited by pacing and leading to a reversible cardiomyopathy.
Atrioventricular nodal re-entry tachycardia is the most common form of regular paroxysmal tachycardia in the adult population. This tachycardia is a re-entrant rhythm that uses the anatomic location of the atrioventricular node and its surrounding perinodal atrial tissue. The simplest concept regarding the atrioventricular nodal physiology that allows re-entry is founded upon the postulated existence of 2 atrioventricular nodal pathways with different conduction velocities and refractory periods. Herein, we present the case of a 64-year-old man who had a history of paroxysmal atrial fibrillation; he had a permanent pacemaker for sick-sinus syndrome. He developed a tachycardia-induced cardiomyopathy with a perpetual dual response to the pacemaker stimulus. The tachycardia displayed characteristic dual atrioventricular-nodal physiology that was suppressed by amiodarone therapy, leading to a reversal of the cardiomyopathy. We discuss the mechanisms that surround such phenomena.
Catanzaro
John N
JN
Department of Cardiology, Division of Electrophysiology, North Shore University Hospital, Manhasset, New York 11030, USA.
Makaryus
John
J
Vafai
Jonathan
J
Makaryus
Amgad N
AN
Jadonath
Ram
R
Beldner
Stuart
S
D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D001283:Atrioventricular Node / Q000503:physiopathology*; D002304:Cardiac Pacing, Artificial / Q000009:adverse effects*; D009202:Cardiomyopathies / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D004562:Electrocardiography; D022062:Electrophysiologic Techniques, Cardiac; D006801:Humans; D008297:Male; D008875:Middle Aged; D012804:Sick Sinus Syndrome / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D013611:Tachycardia, Atrioventricular Nodal Reentry / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone
J Am Coll Cardiol. 1998 Mar 1;31(3):637-44
9502647
Circulation. 1993 Jul;88(1):282-95
8319342
Circ Res. 1966 Aug;19(2):378-93
5914850
Int J Cardiol. 1996 Sep;56(1):75-81
8891808
Circulation. 2001 Jun 5;103(22):2660-7
11390334
Am J Cardiol. 1993 Sep 1;72(7):560-6
8362771
Circulation. 1991 Feb;83(2):635-44
1991381
Circ J. 2007 Jun;71(6):936-40
17526993
Indian Pacing Electrophysiol J. 2003 Jan 01;3(1):3-9
16943985
Pacing Clin Electrophysiol. 1996 Jan;19(1):42-9
8848376
Europace. 2001 Jul;3(3):216-20
11467463
Am Heart J. 1996 Oct;132(4):758-64
8831362
Am J Cardiol. 1992 Apr 15;69(12):1028-32
1561973